ArticleAntimicrobial resistance and infection control2022
Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries.
Article in Antimicrobial resistance and infection control, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Assessing the implementation determinants of antimicrobial stewardship programmes in sub-Saharan Africa through the complexity lens. A CFIR-guided systematic review.Frontiers in microbiology · 2025Pooled it
- The impact of antimicrobial stewardship interventions on appropriate use of surgical antimicrobial prophylaxis in low- and middle-income countries: a systematic review.Systematic reviews · 2024Pooled it
- Substandard and falsified antimicrobials in selected east African countries: A systematic review.PloS one · 2024Pooled it
- Governance of antimicrobial resistance in Central Africa (2015-2025): a systematic review of policies, One Health coordination and funding.JAC-antimicrobial resistance · 2026Review
- Mind the governance gap: a one health scoping review of national AMR performance indicators.npj antimicrobials and resistance · 2026Article
- Governing antibiotic resistance through One Health: Insights from the political and legal landscape in Senegal.PLOS global public health · 2026Article
- Prioritization of antimicrobial resistance surveillance of gram-negative pathogens - a stacked modelling approach.Wellcome open research · 2026Article
- Tackling Antimicrobial Resistance in the WHO African Region: Progress, Challenges, and Strategic Priorities for the Future.Health services insights · 2026Article
- Using implementation science to bridge the gaps between political commitment and action in antimicrobial resistance governance under the one health approach in the WHO Southeast Asia and Western Pacific regions.The Lancet regional health. Western Pacific · 2026Review
- Beyond symbolic participation: youth-led organisations' voices and actions against antimicrobial resistance in Africa South of the Sahara.Global health action · 2025Article
- Corruption, poverty and inflation as enablers of AMR in low- and middle-income countries: finding the link and addressing the gaps.JAC-antimicrobial resistance · 2025Review
- Antimicrobial Use and Manure Management Among Pig and Poultry Farmers in Malawi.Antibiotics (Basel, Switzerland) · 2025Article
- Digital pulse: Social media reaction to South Africa's National Health Insurance implementation.African journal of primary health care & family medicine · 2025Article
- Genome Characteristic of NDM-5-ProducingInfection and drug resistance · 2025Article
- Association between national action and trends in antibiotic resistance: an analysis of 73 countries from 2000 to 2023.PLOS global public health · 2025Article
- Exploring antibiotic stewardship interventions within a One Health context: a scoping review.Frontiers in public health · 2025Article
- Perspectives on the Regional Strategy for Implementation of National Action Plans on Antimicrobial Resistance in the WHO African Region.Antibiotics (Basel, Switzerland) · 2024Article
- Antimicrobial resistance in China across human, animal, and environment sectors - a review of policy documents using a governance framework.The Lancet regional health. Western Pacific · 2024Review
- Article
- Assessment of challenges and opportunities in antibiotic stewardship program implementation in Northwest Ethiopia.Heliyon · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
backgroundAntimicrobial resistance (AMR) poses an increasing public health threat to low- and lower-middle income countries. Recent studies found that in fact poor governance and transparency correlate more strongly with AMR than factors such as antibiotic use. While many African countries now have national action plans (NAPs) on AMR, it is unclear whether information is publicly available on their implementation, surveillance and financing.
methodsHere, the transparency of information related to AMR national action plans in 15 African countries is assessed, based on a governance framework for AMR action plans. Public availability is assessed for AMR documents, progress reports, AMR surveillance data, budget allocations, as well as bodies and persons responsible for implementation of NAPs. Government websites and search engines were perused using search terms related to the studied criteria and countries.
resultsResults show that most countries have a national action plan publicly available. AMR surveillance data was available for a few countries, but systematic progress reports and funding allocations were absent in all but one country. Information on a body mandated to coordinate NAP implementation was available for most countries, but their functionality remain unclear. Most countries have nominated at least one person responsible for AMR nationally. In general, information was often fragmented and frequently available on external, non-government websites. It appears that commitments on AMR made in the often comprehensive NAPs are rarely met in a timely manner, exhibiting rather weak accountability for AMR results. The article provides concrete policy recommendations on how transparency and accountability may be improved with little effort.
conclusionsMaking information available can enable stakeholders such as civil society to demand accountability for results and lead to much needed specific actions on curbing AMR in countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.